Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon
Daniel Addison, MD, Director of Translational Research in the Cardiology Division and Associate Director for Survivorship and Outcomes Research in the Harold C. Simmons Comprehensive Cancer Center. He also holds the Audre and Bernard Rapport Endowed Chair in Cardiovascular Research, UT Southwestern Medical Center. explains the health disparities and inequities involved in cardio-oncology.

How clinicians can combat health disparities in cardio-oncology

Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business. 

Thumbnail

Using chest X-rays for triage could reduce lung cancer overdiagnoses

Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research. 

As cancer therapies become increasingly targeted and complex, the need for sophisticated cardiovascular monitoring has grown in parallel. Cardiovascular Business spoke with Daniel Addison, MD, director of the cardio-oncology program at The Ohio State University and chair of the American Heart Association’s (AHA) Cardiac Imaging Committee, who said the use of multimodality imaging is transforming how clinicians manage cardiovascular risk in cancer patients and survivors.

Multimodality imaging is more important than ever to the field of cardio-oncology

“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.

Lung cancer screening stethoscope

AI outperforms radiologists at predicting cancer treatment response based on imaging

These findings have the potential to change how treatment decisions are made in the future, researchers suggest.

Thumbnail

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly. 

Late-stage prostate cancer diagnoses on the rise

Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers. 

Dual-mode radiotracer helps surgeons 'hear' invisible cancer lesions

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 

Molecular Imaging PET and SPECT sign in GE booth ACC23.

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

Displaying 17 - 24 of 447
Design by Adaptive Theme